- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/57 - Aryl or substituted aryl radicals
Patent holdings for IPC class C07D 263/57
Total number of patents in this class: 354
10-year publication summary
|
28
|
33
|
23
|
28
|
31
|
35
|
30
|
32
|
20
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17970 |
13 |
| Hodogaya Chemical Co., Ltd. | 434 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
8 |
| Lapto Co., Ltd. | 40 |
8 |
| Sumitomo Chemical Company, Limited | 8965 |
7 |
| Unigen, Inc. | 103 |
6 |
| Pfizer Inc. | 3418 |
5 |
| Merck Patent GmbH | 5747 |
5 |
| Aldeyra Therapeutics, Inc. | 101 |
5 |
| Incyte Corporation | 1065 |
5 |
| Metabasis Therapeutics, Inc. | 38 |
5 |
| FUJIFILM Corporation | 30689 |
4 |
| Semiconductor Energy Laboratory Co., Ltd. | 11896 |
4 |
| Arcus Biosciences, Inc. | 166 |
4 |
| CHDI Foundation, Inc. | 108 |
4 |
| King Faisal University | 936 |
4 |
| Novaled GmbH | 491 |
4 |
| University of Houston System | 1130 |
4 |
| Boehringer Ingelheim International GmbH | 4479 |
3 |
| Syngenta Participations AG | 1479 |
3 |
| Other owners | 245 |